Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 11, 2016 9:29 PM ET

Biotechnology

Company Overview of CareDx, Inc

Company Overview

CareDx, Inc, a commercial stage company, develops, markets, and delivers diagnostic surveillance solutions for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient’s lifetime. Its commercialized testing solution includes the AlloMap heart transplant molecular test (AlloMap), a blood-based test used to monitor heart transplant recipients for acute cellular rejection. The company markets its AlloMap solution to healthcare providers through its direct sales force that targets transplant centers and their physicians, coordinators, and nurse practitioners in the United States, Canada, and Europe. The company was formerly known as XDx...

3260 Bayshore Boulevard

Brisbane, CA 94005

United States

Founded in 1998

68 Employees

Phone:

415-287-2300

Fax:

415-287-2450

Key Executives for CareDx, Inc

Chief Executive Officer, President and Director
Age: 48
Total Annual Compensation: $547.6K
Chief Medical Officer and Executive Vice President
Age: 66
Total Annual Compensation: $524.5K
Chief Compliance Officer and Chief Business Officer
Age: 45
Total Annual Compensation: $445.5K
Compensation as of Fiscal Year 2014.

CareDx, Inc Key Developments

CareDx, Inc Presents at The Leerink Partners 5th Annual Global Healthcare Conference, Feb-10-2016 09:15 AM

CareDx, Inc Presents at The Leerink Partners 5th Annual Global Healthcare Conference, Feb-10-2016 09:15 AM. Venue: The Waldorf Astoria, New York, New York, United States. Speakers: Peter Maag, Chief Executive Officer, President and Director.

CareDx and Diaxonhit Announce Completion of Technology Transfer of Allomap® Test in Europe

CareDx Inc. and Diaxonhit have announced the completion of the transfer of the CareDx proprietary AlloMap gene expression test into the Strasbourg University Hospital Central Immunology Laboratory (HUS) in France. This rigorous, multi-step validation process has demonstrated that AlloMap test results released from the HUS laboratory are equivalent to AlloMap results generated by the CareDx main laboratory in the United States. With the completion of this technology transfer, patient samples can now be tested at HUS. This transfer is a significant milestone for CareDx and its exclusive European licensee and commercial partner, Diaxonhit, which contracted with Strasbourg University Hospital in 2014 to be the dedicated testing laboratory for AlloMap throughout Europe. This technology transfer is the first of its kind, and was completed through a strong collaboration among commercial, technical and development teams at CareDx, Diaxonhit and HUS. Diaxonhit has utilized its expertise in transplantation to design health economic studies for AlloMap reimbursement in Europe. The French Ministry of Health has recently approved the funding of a study designed to demonstrate that AlloMap is non-inferior to biopsy to inform about the risk of acute cellular rejection among French heart transplant patients.

Allenex AB (publ), CareDx, Inc - M&A Call

To discuss acquisition of 78% of the outstanding shares of Allenex AB

Similar Private Companies By Industry

Company Name Region
Agrinomics United States
Modular Genetics, Inc. United States
Lysosomal Therapeutics Inc. United States
Kala Pharmaceuticals, Inc. United States
Applied Catheter Technologies, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
December 16, 2015
Allenex AB (publ)
Merger/Acquisition
December 16, 2015
Allenex AB (publ)
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CareDx, Inc, please visit www.caredx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.